TY - JOUR AU - Lyerly, A. D. AU - Little, M. O. AU - Faden, R. PY - 2008 DA - 2008// TI - The second wave: toward responsible inclusion of pregnant women in research JO - Int J Fem Approaches Bioeth. VL - 1 UR - https://doi.org/10.3138/ijfab.1.2.5 DO - 10.3138/ijfab.1.2.5 ID - Lyerly2008 ER - TY - JOUR AU - Little, M. AU - Lyerly, A. AU - Faden, R. PY - 2009 DA - 2009// TI - Pregnant women and medical research: a moral imperative JO - Bioethica Forum. VL - 2 ID - Little2009 ER - TY - JOUR AU - Baylis, F. PY - 2010 DA - 2010// TI - Pregnant women deserve better JO - Nature. VL - 465 UR - https://doi.org/10.1038/465689a DO - 10.1038/465689a ID - Baylis2010 ER - TY - STD TI - Council for International Organizations of Medical Sciences and World Health Organizaion. CIOMS draft guidelines. 2016. Available from: http://www.cioms.ch/index.php. Accessed 20 May 2017. UR - http://www.cioms.ch/index.php ID - ref4 ER - TY - JOUR AU - Shields, K. E. AU - Lyerly, A. D. PY - 2013 DA - 2013// TI - Exclusion of pregnant women from industry-sponsored clinical trials JO - Obstet Gynecol. VL - 122 UR - https://doi.org/10.1097/AOG.0b013e3182a9ca67 DO - 10.1097/AOG.0b013e3182a9ca67 ID - Shields2013 ER - TY - JOUR AU - Haas, D. M. AU - Gallauresi, B. AU - Shields, K. AU - Zeitlin, D. AU - Clark, S. M. AU - Hebert, M. F. PY - 2011 DA - 2011// TI - Pharmacotherapy and pregnancy: highlights from the third international conference for individualized pharmacotherapy in pregnancy JO - Clin Transl Sci. VL - 4 UR - https://doi.org/10.1111/j.1752-8062.2011.00280.x DO - 10.1111/j.1752-8062.2011.00280.x ID - Haas2011 ER - TY - JOUR AU - Lupattelli, A. AU - Spigset, O. AU - Twigg, M. J. AU - Zagorodnikova, K. AU - Mårdby, A. C. AU - Moretti, M. E. PY - 2014 DA - 2014// TI - Medication use in pregnancy: a cross-sectional, multinational web-based study JO - BMJ Open. VL - 4 UR - https://doi.org/10.1136/bmjopen-2013-004365 DO - 10.1136/bmjopen-2013-004365 ID - Lupattelli2014 ER - TY - STD TI - European Medicines Agency. Guideline of the exposure to medicinal products during pregnancy: need for post-authorisation data. 2005. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/11/WC500011303.pdf. Accessed 25 Mar 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/11/WC500011303.pdf ID - ref8 ER - TY - STD TI - Noah BA. The inclusion of pregnant women in clinical research. St. Louis J Health Law Policy. 2014;7:353–89. http://digitalcommons.law.wne.edu/cgi/viewcontent.cgi?article=1297&context=facschol. UR - http://digitalcommons.law.wne.edu/cgi/viewcontent.cgi?article=1297&context=facschol ID - ref9 ER - TY - BOOK PY - 2011 DA - 2011// TI - Enrolling pregnant women: issues in clinical research PB - National Institutes of Health CY - Bethesda, MD ID - ref10 ER - TY - STD TI - The Second Wave Initiative. Available from: http://secondwaveinitiative.org/. Accessed 20 May 2017. UR - http://secondwaveinitiative.org ID - ref11 ER - TY - STD TI - American College of Obstetricians and Gynecologists. ACOG statement on FDA pregnancy labeling final rule. 2014. Available from: http://www.acog.org/About-ACOG/News-Room/Statements/2014/ACOG-Statement-on-FDA-Pregnancy-Labeling-Final-Rule. Accessed 24 May 2016. UR - http://www.acog.org/About-ACOG/News-Room/Statements/2014/ACOG-Statement-on-FDA-Pregnancy-Labeling-Final-Rule ID - ref12 ER - TY - STD TI - Cain J, Lowell J, Thorndyke L, Localio AR. Contraceptive requirements for clinical research. Obstet Gynecol. 2000:861–6. ID - ref13 ER - TY - CHAP AU - van der Zande, I. S. E. AU - van der Graaf, R. AU - Browne, J. L. AU - van Delden, J. J. M. ED - Baylis, F. ED - Ballantyne, A. PY - 2016 DA - 2016// TI - Fair inclusion of pregnant women in clinical research: a systematic review of reported reasons for exclusion BT - Clinical trials involving pregnant women PB - Springer International Publishing CY - Switzerland UR - https://doi.org/10.1007/978-3-319-26512-4_5 DO - 10.1007/978-3-319-26512-4_5 ID - van der Zande2016 ER - TY - JOUR AU - Blehar, M. C. AU - Spong, C. AU - Grady, C. AU - Goldkind, S. F. AU - Sahin, L. AU - Clayton, J. A. PY - 2013 DA - 2013// TI - Enrolling pregnant women: issues in clinical research JO - Womens Health Issues. VL - 23 UR - https://doi.org/10.1016/j.whi.2012.10.003 DO - 10.1016/j.whi.2012.10.003 ID - Blehar2013 ER - TY - JOUR AU - Frew, P. M. AU - Saint-Victor, D. S. AU - Isaacs, M. B. AU - Kim, S. AU - Swamy, G. K. AU - Sheffield, J. S. PY - 2014 DA - 2014// TI - Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices JO - Clin Infect Dis. VL - 59 UR - https://doi.org/10.1093/cid/ciu726 DO - 10.1093/cid/ciu726 ID - Frew2014 ER - TY - STD TI - European Medicines Agency. ICH 8 Note for guidance on general considerations for clinical trials”, paragraph 3.1.4.3 Special Populations, a) Investigations in pregnant women. http://www.ema.europe.eu/docs/en_GB/document_library/Scientific_Guideline/2009/09/WC500002877.pdf. Accessed 12 Feb 2018. UR - http://www.ema.europe.eu/docs/en_GB/document_library/Scientific_Guideline/2009/09/WC500002877.pdf ID - ref17 ER - TY - STD TI - Little BB. Pharmacokinetics during pregnancy: Evidence-based maternal dose formulation. Obstet Gynecol. 1999:858–68. ID - ref18 ER - TY - JOUR AU - Mattison, D. AU - Zajicek, A. PY - 2006 DA - 2006// TI - Gaps in knowledge in treating pregnant women JO - Gend Med. VL - 3 UR - https://doi.org/10.1016/S1550-8579(06)80205-6 DO - 10.1016/S1550-8579(06)80205-6 ID - Mattison2006 ER - TY - JOUR AU - Halperin, S. A. PY - 2012 DA - 2012// TI - Research involving pregnant women JO - Trials Tribul. VL - 2 ID - Halperin2012 ER - TY - BOOK AU - de Visser, S. J. PY - 2003 DA - 2003// TI - A question based approach to drug development. Doctoral thesis PB - Leiden University CY - Centre for Human Drug Research ID - de Visser2003 ER - TY - STD TI - de Visser SJ, Tuk B, van Gerven JMA, Cohen AF. Drug development project management by a new question based approach and decision analysis support. Scrip Mag. 2003. ID - ref22 ER - TY - JOUR AU - Sheiner, L. B. PY - 1997 DA - 1997// TI - Learning versus confirming in clinical drug development* JO - Clin Pharmacol Ther. VL - 61 UR - https://doi.org/10.1016/S0009-9236(97)90160-0 DO - 10.1016/S0009-9236(97)90160-0 ID - Sheiner1997 ER - TY - STD TI - European Medicines Agency. Reflection paper on methodological issues in confirmatory clinical trials planned with an adaptive design (CHMP/EWP/2459/02). 2007. Available from http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003616.pdf. Accessed 31 Dec 2017. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003616.pdf ID - ref24 ER - TY - JOUR AU - Bauer, P. AU - Köhne, K. PY - 1994 DA - 1994// TI - Evaluation of experiments with adaptive interim analyses JO - Biometrics. VL - 50 UR - https://doi.org/10.2307/2533441 DO - 10.2307/2533441 ID - Bauer1994 ER - TY - JOUR AU - Sheffield, J. S. AU - Siegel, D. AU - Mirochnick, M. AU - Heine, R. P. AU - Nguyen, C. AU - Bergman, K. L. PY - 2014 DA - 2014// TI - Designing drug trials: considerations for pregnant women JO - Clin Infect Dis. VL - 59 UR - https://doi.org/10.1093/cid/ciu709 DO - 10.1093/cid/ciu709 ID - Sheffield2014 ER - TY - STD TI - Study of hepatitis C treatment during pregnancy. Phase I pharmacokinetic and safety trial of ledipasvir/sofosbuvir fixed dose combination in pregnant women with chronic hepatitis C virus infection. Available from https://clinicaltrials.gov/ct2/show/NCT02683005. Accessed 31 Dec 2017. UR - https://clinicaltrials.gov/ct2/show/NCT02683005 ID - ref27 ER - TY - STD TI - A randomized, open-label, phase 2, multicenter safety and exploratory efficacy study of investigational anti-influenza immune plasma for the treatment of influenza. Available from https://clinicaltrials.gov/ct2/show/NCT01052480. Accessed 5 Jan 2018. UR - https://clinicaltrials.gov/ct2/show/NCT01052480 ID - ref28 ER - TY - JOUR AU - Grouin, J. M. AU - Coste, M. AU - Lewis, J. PY - 2005 DA - 2005// TI - Subgroup analyses in randomized clinical trials: statistical and regulatory issues JO - J Biopharm Stat. VL - 15 UR - https://doi.org/10.1081/BIP-200067988 DO - 10.1081/BIP-200067988 ID - Grouin2005 ER - TY - JOUR AU - Briggs, G. G. AU - Polifka, J. E. AU - Wisner, K. L. AU - Gervais, E. AU - Miller, R. K. AU - Berard, A. PY - 2015 DA - 2015// TI - Should pregnant women be included in phase IV clinical drug trials? JO - Am J Obstet Gynecol. VL - 213 UR - https://doi.org/10.1016/j.ajog.2015.05.047 DO - 10.1016/j.ajog.2015.05.047 ID - Briggs2015 ER -